CompletedPhase 1NCT00246467
One Year Study to Evaluate Three Different Adjuvanted Doses of the Recombinant Plague Vaccine (rF1 and rV Antigens)
Studying Plague
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- PharmAthene UK Limited
- Principal Investigator
- Eric Sheldon, MDMiami Clinical Research
- Intervention
- Alhydrogel(biological)
- Enrollment
- 123 target
- Eligibility
- 18-55 years · All sexes
- Timeline
- 2005 – 2007
Study locations (10)
- Accelovance, Huntsville, Alabama, United States
- Accelovance, Washington D.C., District of Columbia, United States
- Florida Medical Research Institute, Gainesville, Florida, United States
- Accelovance, Melbourne, Florida, United States
- Miami Research Associates, Miami, Florida, United States
- Radiant Research, Pinellas Park, Florida, United States
- Accelovance, South Bend, Indiana, United States
- Lynn Health Science Institute, Oklahoma City, Oklahoma, United States
- Accelovance, Amarillo, Texas, United States
- Simbec Research Limited, Merthyr Tydfil, United Kingdom
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00246467 on ClinicalTrials.govOther trials for Plague
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07207408Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of AgeDynavax Technologies Corporation
- RECRUITINGPHASE1NCT06943378Ph1, Randomized, Double-Blind and Controlled, Dose Escalation and Expansion Study to Assess the Safety and Pharmacokinetics of JST-010 in Healthy AdultsJust-Evotec Biologics
- RECRUITINGNANCT06083649The Dental Care Revolution: Health Education Using AI or Humanized Counseling on Plague Control and Periodontal Treatment Outcome in Patients With Periodontal DiseaseKaohsiung Medical University Chung-Ho Memorial Hospital